2. Gene
  3. CAPS - calcyphosine Gene

CAPS - calcyphosine Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Canis lupus familiaris (sub-species: familiaris)
Gene ID: 403965 | Gene type: protein coding

About CAPS

CAPS Products(1)

mRNA Protein Name
NM_001003282.1 NP_001003282.1 calcyphosin
Protein Preferred Names Protein Names

calcyphosin

TPP

protein 5

thyroid protein p24

Related Agents

Approval
Bioactive Molecules (11)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-109025 Baloxavir marboxil Inhibitor 99.96% Unkown
HY-109025A Baloxavir Inhibitor 99.82% Unkown
HY-101082 N6,2′-O-Dimethyladenosine Inhibitor 99.93% Unkown
HY-A0148A Halofantrine hydrochloride Inhibitor 99.90% Yes
HY-17452A Cefditoren Pivoxil Inhibitor 99.29% Unkown
HY-109025R Baloxavir marboxil (Standard) Inhibitor 99.90% Unkown
HY-17452 Cefditoren sodium Inhibitor 99.70% Unkown
HY-116229 Gemifloxacin Inhibitor / Unkown
HY-A0148 Halofantrine Inhibitor / Unkown
HY-17452AR Cefditoren Pivoxil (Standard) Inhibitor / Unkown
HY-A0148AR Halofantrine hydrochloride (Standard) Inhibitor / Unkown
Clinical Phase
Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Phase
HY-D0869 CAPS 99.95% Phase 4
HY-W751835 Baloxavir-d4 99.27% Phase 4
HY-145586 Onradivir Inhibitor 99.53% Phase 3
HY-145586A Onradivir monohydrate Inhibitor / Phase 3
HY-143744 Suraxavir marboxil Inhibitor / Phase 3
HY-139553 Zunsemetinib Inhibitor 99.99% Phase 2
HY-105172 TT-232 Agonist 98.72% Phase 2
HY-12914 V116517 Antagonist / Phase 2
Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Phase
HY-P991900 LY3541860 Inhibitor ≥99.0% Phase 2
HY-P991224 CAP-100 Inhibitor 99.84% Phase 1
Pre-clinical Phase
Bioactive Molecules (213)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-N0086 N6-Methyladenosine Inhibitor 99.84% Unkown
HY-145974A m7GpppAmpG ammonium solution (100 mM) 99.96% Unkown
HY-153040 HPPE Inhibitor 99.71% Unkown
HY-15523 Braco-19 Inhibitor 98.01% Unkown
HY-14427 4E1RCat Inhibitor 99.04% Unkown
HY-122524 7-Methylguanosine Inhibitor 99.10% Unkown
HY-162543 18:1 Liss Rhod PE 99% Unkown
HY-139100B m7G(5')ppp(5')A diammonium 99.15% Unkown
HY-148771 MTX-23 99.79% Unkown
HY-79096 Boc-L-phenylalanine 99.84% Unkown
HY-21586B 7-Methyl-guanosine-5'-triphosphate sodium 92.36% Unkown
HY-15523A Braco-19 trihydrochloride Inhibitor 99.57% Unkown
HY-N0086S N6-Methyladenosine-d3 Inhibitor 99.97% Unkown
HY-N2362 DL-Alanine 98.0% Unkown
HY-139101A Guanosine 5'-triphosphate-5'-adenosine triammonium 99.96% Unkown
HY-174497 eGFP mRNA 90% Unkown
HY-153108 3'-O-Me-m7G(5')ppp(5')A solution (100 mM) Chemical 99.43% Unkown
HY-156048 Trifluoromethyl-tubercidin Inhibitor 99.90% Unkown
HY-109659 1-(3-Aminopropyl)-4-methylpiperazine 99.07% Unkown
HY-145969A β-S-ARCA triammonium 99.48% Unkown
HY-145973A 3'OMe-m7GpppAmpG ammonium solution (100 mM) Modulator 98.24% Unkown
HY-107823 Cholesteryl acetate 99.21% Unkown
HY-141472 7-Methylguanosine 5'-diphosphate sodium 97.10% Unkown
HY-18684 SIBA Inhibitor 99.64% Unkown
HY-145975A m7Gpppm6AmpG ammonium solution (100 mM) 98.26% Unkown
HY-135517 RXP470.1 Inhibitor 99.60% Unkown
HY-158772 m7G(5')ppp(5')(2'OMeA)pU ammonium solution (100 mM) 99.6% Unkown
HY-W441004 DSPE-Thiol 90.0% Unkown
HY-178674A Im-m7GDP sodium 89.15% Unkown
HY-W028714 2,3-Diphenylquinoxaline-6-carboxylic acid 99.95% Unkown
HY-W110707 Cetylamine 98.0% Unkown
HY-14956 Nemonoxacin Inhibitor 99.77% Unkown
HY-133887 Methotrexate α-tert-butyl ester Inhibitor 97.38% Unkown
HY-164927 AV5124 Inhibitor 99.11% Unkown
HY-D0948 Celestine Blue 66.00% Unkown
HY-N6772 Cytochalasin E Inhibitor 99.90% Unkown
HY-122524AR 7-Methylguanosine iodide (Standard) Inhibitor 98.50% Unkown
HY-132894 Pixavir marboxilo 99.53% Unkown
HY-164188 m7(3'Ma-Cy5)Gppp(2'OMe)ApG triammonium 98% Unkown
HY-164190 m7(3'Ma-Biotin)Gppp(2'OMe)ApG ammonium solution (25mM) 90.00% Unkown
HY-177555 AV5116 Inhibitor 99.57% Unkown
HY-E70080 Vaccinia virus capping enzyme / Unkown
HY-E70081 mRNA Cap 2'-O-methyltransferase / Unkown
HY-145977A m7GpppGmpG ammonium solution (100 mM) Modulator 95.07% Unkown
HY-139100 N7-Methyl-guanosine-5'-triphosphate-5'-adenosine / Unkown
HY-145538 2'-Deoxyguanosine 5'-monophosphate disodium hydrate 99.0% Unkown
HY-145969 β-S-ARCA / Unkown
HY-159855 CAP 2 hydrochloride 97.6% Unkown
HY-170524 TDI-015051 Inhibitor / Unkown
HY-N2362S DL-Alanine-13C-1 98.0% Unkown
HY-N2362S1 DL-Alanine-13C-3 98.0% Unkown
HY-RS01823 CADPS Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W996116 AZM198 Inhibitor 98.40% Unkown
HY-113897 Chloramphenicol 3-acetate 98.97% Unkown
HY-145913A m7GpppApG triammonium solution (100 mM) 99.28% Unkown
HY-160957 Cap A (Acetonitrile/Acetic Anhydride, 80/20 v/v) 99.97% Unkown
HY-160958 Cap B Acetonitrile/N-methylimidazole /pyridine, 50/20/30 v/v/v / Unkown
HY-164192A m7(3'AcmG)(5')ppp(5')(2'OMeA)pG trisodium solution (100 mM) 98.61% Unkown
HY-178672 ARCA / Unkown
HY-178672A ARCA triammonium solution (100 mM) / Unkown
HY-N0086S2 N6-Methyladenosine-13C4 Inhibitor 99.8% Unkown
HY-N2362S2 DL-Alanine-d3 98.0% Unkown
HY-109025AS2 Baloxavir-d1 Inhibitor / Unkown
HY-105172A TT-232 TFA Agonist / Unkown
HY-109025AS Baloxavir-d5 Inhibitor / Unkown
HY-122524AS 7-Methylguanosine-13C,d3 iodide / Unkown
HY-122524AS1 7-Methylguanosine-13C iodide / Unkown
HY-123702 CAP-53194 / Unkown
HY-131736 3'-O-Bn-GTP / Unkown
HY-134809A Cyclotriazadisulfonamide hydrochloride Inhibitor / Unkown
HY-139553A (R)-Zunsemetinib Control 97.84% Unkown
HY-143743 Cap-dependent endonuclease-IN-2 / Unkown
HY-143747 Cap-dependent endonuclease-IN-5 / Unkown
HY-143749 Cap-dependent endonuclease-IN-6 Inhibitor / Unkown
HY-143750 Cap-dependent endonuclease-IN-7 / Unkown
HY-143752 Cap-dependent endonuclease-IN-8 / Unkown
HY-143755 Cap-dependent endonuclease-IN-9 / Unkown
HY-143757 Cap-dependent endonuclease-IN-10 / Unkown
HY-143762 Cap-dependent endonuclease-IN-12 Inhibitor / Unkown
HY-143766 Cap-dependent endonuclease-IN-13 / Unkown
HY-143768 Cap-dependent endonuclease-IN-14 / Unkown
HY-143769 Sebaloxavir marboxil / Unkown
HY-143770 Cap-dependent endonuclease-IN-16 / Unkown
HY-143771 Cap-dependent endonuclease-IN-17 Inhibitor / Unkown
HY-143775 Cap-dependent endonuclease-IN-20 Inhibitor / Unkown
HY-143776 Cap-dependent endonuclease-IN-22 Inhibitor / Unkown
HY-143781 Cap-dependent endonuclease-IN-26 Inhibitor / Unkown
HY-144065 Cap-dependent endonuclease-IN-19 / Unkown
HY-144066 Cap-dependent endonuclease-IN-21 / Unkown
HY-144067 Cap-dependent endonuclease-IN-23 / Unkown
HY-144068 Cap-dependent endonuclease-IN-25 / Unkown
HY-145502 1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) sodium 99.48% Unkown
HY-145973 3'OMe-m7GpppAmpG Modulator / Unkown
HY-145973B 3'OMe-m7GpppAmpG Tris Inhibitor / Unkown
HY-145975 m7Gpppm6AmpG / Unkown
HY-145977 m7GpppGmpG Modulator / Unkown
HY-145979 m7GpppUmpG / Unkown
HY-145980 m7GpppUpG / Unkown
HY-145981 m7GpppCpG / Unkown
HY-145982 m7GpppCmpG / Unkown
HY-147339 M7G(3'-OMe-5')pppA(2'-OMe) / Unkown
HY-147730 HDAC6-IN-8 / Unkown
HY-148664 eIF4E-IN-4 Inhibitor / Unkown
HY-149263 HAA-09 Inhibitor / Unkown
HY-150144 Uracil-m7GpppAmpG ammonium solution (100 mM) Modulator / Unkown
HY-153570 Influenza virus-IN-7 Inhibitor / Unkown
HY-155337 eIF4E-IN-6 Inhibitor / Unkown
HY-155676 eIF4E-IN-5 Inhibitor / Unkown
HY-157339 MMT-2'-O-Methyl adenosine (n-bz) CED phosphoramidite / Unkown
HY-158819 m7(3'OMeG)(5')ppp(5')m6(2'OMeA)pG trisodium / Unkown
HY-162242 Cap-dependent endonuclease-IN-27 Inhibitor / Unkown
HY-163498 NLRP3-IN-37 Inhibitor / Unkown
HY-163621 Cap-dependent endonuclease-IN-28 Inhibitor / Unkown
HY-164189 m7(3'Ma-Cy3)Gppp(2'OMe)ApG ammonium / Unkown
HY-164191 m7(3'Ma-Peg5-FAM)Gppp(2'OMe)ApG ammonium / Unkown
HY-164193 m7(3'AcmG)(5')ppp(5')(2'OMeA)pU ammonium / Unkown
HY-170523 RU-0415529 Inhibitor / Unkown
HY-176278 mPEG1000-LA / Unkown
HY-176278A mPEG2000-LA / Unkown
HY-176278B mPEG3400-LA / Unkown
HY-176278C mPEG5000-LA / Unkown
HY-178045 MYC-IN-4 Inhibitor / Unkown
HY-178145 Mc-Lys(PEG12)-Cap-Ala-Ala-PABC-exatecan Inhibitor / Unkown
HY-178146 Mc-Lys(PEG12)-Cap-Ala-Ala-PABC / Unkown
HY-178673S m7G(5')ppp(5')(2'OMeA)-d3 ammonium / Unkown
HY-179556 SARS-CoV-2 nsp14-IN-10 / Unkown
HY-179761 16:0 C4-BODIPY 505/515 DNP Cap PE ammonium / Unkown
HY-181495 RAJQ14 Degrader / Unkown
HY-181498 RAFKBP12 / Unkown
HY-181499 RA190-PEG1-NH2 / Unkown
HY-181521 RAPRMT5 / Unkown
HY-181523 RA183 Ligand / Unkown
HY-181524 RA183-CO-C6-NHCO-NH-Boc Ligand / Unkown
HY-182487 Deoxaphomin / Unkown
HY-185601 m7(3'-OMeG)(5')vppp(5')(2'-OMe, m6A)pU triammonium / Unkown
HY-185602 m7G(5')vppp(5')(2'OMeA)pG triammonium / Unkown
HY-185603 m7G(LNA)(5')ppp(5')(2'OMe, m6A)pG trisodium / Unkown
HY-185609 m7G(2'F)(5')ppp(5')(2'OMeA)pG triammonium / Unkown
HY-185611 A(5')ppp(5')(2'-OMeA)pG tetraammonium / Unkown
HY-185612 m7G(5')vppp(5')(2'-OMeA)pU triammonium / Unkown
HY-185613 m7G(UNA)(5')ppp(5')(2'OMeA)pG triammonium / Unkown
HY-185614 m7(3'OMeG)(5')ppp(5')A ammonium / Unkown
HY-185615 m7G(HNA)(5')ppp(5')(2'OMeA)pG triammonium / Unkown
HY-185617 m7(3'OMeG-LNA)(5')ppp(5')(2'OMe,m6A)pG trisodium / Unkown
HY-21586 7-Methyl-guanosine-5'-triphosphate disodium / Unkown
HY-79096S BOC-L-Phenylalanine-13C / Unkown
HY-79096S2 BOC-L-phenylalanine-d8 / Unkown
HY-D0869S 3-(Cyclohexylamino)-1-propanesulfonic Acid-d17 / Unkown
HY-E70405 Guanylyltransferase / Unkown
HY-N0086S3 N6-Methyladenosine-13C3 Inhibitor / Unkown
HY-N15772 16:0 Folate cap PE disodium / Unkown
HY-N15882 16:0 DNP Cap PE monoammonium / Unkown
HY-N2362S5 DL-Alanine-15N / Unkown
HY-N7647 Methyl brevifolincarboxylate Inhibitor / Unkown
HY-P2458 CAP18 (rabbit) Inhibitor / Unkown
HY-P3911 CAP 37 (20-44) / Unkown
HY-RS01880 CAP1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01881 CAP2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01899 CAPS Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01900 CAPS2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W1143084A m7G(5')ppp(5' )(2'OMeG) ammonium / Unkown
HY-W340832 18:1 Biotinyl Cap PE / Unkown
HY-W423489 SARS-CoV-2-IN-76 Inhibitor / Unkown
HY-115693 CAP 3 Inhibitor / Unkown
HY-122524A 7-Methylguanosine iodide Inhibitor / Unkown
HY-131736A 3'-O-Bn-GTP sodium / Unkown
HY-139098 7-Methyl-diguanosine triphosphate / Unkown
HY-139101 Guanosine 5'-triphosphate-5'-adenosine / Unkown
HY-145913 m7GpppApG / Unkown
HY-145974 m7GpppAmpG / Unkown
HY-145976 m7GpppGpG / Unkown
HY-151829 Fmoc-L-Asn(EDA-N3)-OH / Unkown
HY-157504 2′-O-Methyl-5′-O-phosphonoadenylyl-(3′→5′)-guanosine TEA / Unkown
HY-158819B m7(3'OMeG)(5')ppp(5')m6(2'OMeA)pG tetraammonium solution (100 mM) 99.18% Unkown
HY-164187 m7(3'Ma-Cy7)Gppp(2'OMe)ApG ammonium / Unkown
HY-164192 m7(3'AcmG)(5')ppp(5')(2'OMeA)pG ammonium / Unkown
HY-164984 m3227G(5)ppp(5')A / Unkown
HY-164984A m3227G(5)ppp(5')A triammonium / Unkown
HY-164985 m3227G(5)ppp(5')Am / Unkown
HY-164985A m3227G(5)ppp(5')Am triammonium / Unkown
HY-164986 m3227G(5)ppp(5')m6Am / Unkown
HY-164986A m3227G(5)ppp(5')m6Am triammonium / Unkown
HY-17452AS Cefditoren pivoxil-d3 Inhibitor / Unkown
HY-17452B Cefditoren Pivoxil hydrochloride Inhibitor / Unkown
HY-174791 Cre-T2A-GFP mRNA (N1-Methylpseudo-UTP) / Unkown
HY-174792 Cre-T2A-GFP mRNA / Unkown
HY-178561 CAP 6 m7G(LNA)(5')ppp(5')(2'OMeA)pG / Unkown
HY-178574 CAP m7(3'-OMeG)(5')vppp(5')(2'-OMeA)pU / Unkown
HY-178602 CAP m7G(5')ppp(5')(2'OMeG) / Unkown
HY-178640 CAP m7G(LNA)(5')ppp(5')A(LNA)pG / Unkown
HY-178671 CAP GAU m7G(5')ppp(5')(2'OMeA)pU / Unkown
HY-178674 Im-m7GDP / Unkown
HY-179048 MH44 Inhibitor / Unkown
HY-180162 Influenza A virus-IN-17 Inhibitor / Unkown
HY-181500 AP1867-NH-PEG3-acid Ligand / Unkown
HY-182162 5'-Pyrene cap phosphoramidite / Unkown
HY-182177 5'-Trimethoxystilbene cap phosphoramidite / Unkown
HY-182962 7-Methylguanosine 5-disphosphoimidazolide disodium / Unkown
HY-183592 Anti-virus agent 2 Inhibitor / Unkown
HY-21586A m7GTP / Unkown
HY-79096S1 BOC-L-phenylalanine-d5 / Unkown
HY-N2362S8 DL-Alanine-d7 / Unkown
HY-N2362S9 DL-Alanine-13C2,15N / Unkown
HY-RS17580 Cap2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17877 Cap1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23265 Caps Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24040 Cap2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24346 Cap1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W102681 3-(cyclohexylamino)-1-Propanesulfonic acid sodium salt / Unkown
HY-W112199 9-Anthracenamine / Unkown
HY-W129441 N-Acetyl-4-S-cysteaminylphenol / Unkown
HY-W591314 M-PEG11-Ms / Unkown
HY-W740028 Cefditoren-d3 sodium Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CAPS NCBI NCBI:828